ARTICLE | DealsPlus: Approval for Pfizer’s MM bispecific and updates from Harmony-Zynerba, One Bio-Hengrui, Taysha, Arcturus, BioXcel By BioCentury Staff
August 15, 2023 12:16 AM UTC
Discussions...
Accel Research Sites is the newest member of Alcanza site network. For a brief history of the organization, areas of specialization and growth plans,...
This post has already been read 199 times!
How pharmaceutical brands can use a multi-party, multi-tier network to achieve operational excellence and combat the competition
In...
By Steven Reinberg HealthDay Reporter<!---->WEDNESDAY, July 26, 2023 -- People who carry a gene that's associated with Alzheimer’s disease may lose their sense of...